EL Brown, S Shmuel, K Mandleywala… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The human epidermal growth factor receptor 2 (HER2)–targeting trastuzumab emtansine (T-
DM1) and trastuzumab deruxtecan (T-DXd) are antibody–drug conjugates (ADC) clinically …